ArticleBMC plant biology2025
Identification of genes involved in verazine biosynthesis in Veratrum grandiflorum and their heterologous production in Saccharomyces cerevisiae.
Article in BMC plant biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Reconstruction ofEngineering in life sciences · 2026Article
- Automated Strain Construction for Biosynthetic Pathway Screening in Yeast.ACS synthetic biology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Verazine is a verazine-type alkaloid primarily found in plants of the family Melanthiaceae. In addition to its direct antifungal activity, it serves as a key precursor in the biosynthesis of cyclopamine, a potent inhibitor of the Hedgehog signaling pathway. In this study, we sequenced the transcriptomes of Veratrum grandiflorum roots treated with methyl jasmonate, genes involved in verazine biosynthesis VgCYP90B27, VgCYP94N1, VgCYP90G1, and VgGABAT, were characterized. We produced verazine using Saccharomyces cerevisiae chassis with a yielding 71.62 ± 3.50 µg/L. Furthermore, the GAME4 gene with aldeylation of C-26 was also introduced, and the flask fermentation titer was increased to 175 ± 1.38 µg/L, which was the highest titer reported so far. These results provide a reference for high efficient heterologous biosynthesis study of verazine, and lay a foundation for the deciphering of cyclopamine biosynthetic pathway.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.